Kahn SE - Search Results

1

COVID-19, Hyperglycemia, and New-Onset Diabetes.

Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. Khunti K, et al. Among authors: kahn se. Diabetes Care. 2021 Dec;44(12):2645-2655. doi: 10.2337/dc21-1318. Epub 2021 Oct 8. Diabetes Care. 2021. PMID: 34625431 Free PMC article. Review.

2

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

Porte D Jr, Kahn SE. Porte D Jr, et al. Among authors: kahn se. Diabetes. 1989 Nov;38(11):1333-6. doi: 10.2337/diab.38.11.1333. Diabetes. 1989. PMID: 2695369 Review.

3

Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.

Stone LM, Kahn SE, Deeb SS, Fujimoto WY, Porte D Jr. Stone LM, et al. Among authors: kahn se. Diabetes Care. 1994 Dec;17(12):1480-3. doi: 10.2337/diacare.17.12.1480. Diabetes Care. 1994. PMID: 7882822

4

The GENNID Study. A resource for mapping the genes that cause NIDDM.

Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Permutt MA, Chiu KC, Cruz J, Ehrmann DA, Robertson RP, Rotter JI, Buse J. Raffel LJ, et al. Among authors: kahn se. Diabetes Care. 1996 Aug;19(8):864-72. doi: 10.2337/diacare.19.8.864. Diabetes Care. 1996. PMID: 8842605

5

Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.

Greenbaum CJ, Kahn SE, Palmer JP. Greenbaum CJ, et al. Among authors: kahn se. Diabetes. 1996 Nov;45(11):1631-4. doi: 10.2337/diab.45.11.1631. Diabetes. 1996. PMID: 8866571 Clinical Trial.

6

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY. Kahn SE, et al. Diabetes. 1998 Apr;47(4):640-5. doi: 10.2337/diabetes.47.4.640. Diabetes. 1998. PMID: 9568698

7

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn SE, Andrikopoulos S, Verchere CB. Kahn SE, et al. Diabetes. 1999 Feb;48(2):241-53. doi: 10.2337/diabetes.48.2.241. Diabetes. 1999. PMID: 10334297 Review.

8

beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.

Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE. Andrikopoulos S, et al. Among authors: kahn se. Diabetes. 2000 Dec;49(12):2056-62. doi: 10.2337/diabetes.49.12.2056. Diabetes. 2000. PMID: 11118007

9

Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.

Knowles NG, Landchild MA, Fujimoto WY, Kahn SE. Knowles NG, et al. Among authors: kahn se. Diabetes Care. 2002 Feb;25(2):292-7. doi: 10.2337/diacare.25.2.292. Diabetes Care. 2002. PMID: 11815498

10

Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group. Jensen CC, et al. Among authors: kahn se. Diabetes. 2002 Jul;51(7):2170-8. doi: 10.2337/diabetes.51.7.2170. Diabetes. 2002. PMID: 12086947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

551 results

Search Page